May 2024 Investor Presentation © 2024 Modivcare® Inc. Certain statements contained in herein constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are frequently identified by the use of terms such as "may," "will," "should," "expect," "believe," "estimate," "intend," and similar words indicating possible future expectations, events or actions. The updated guidance discussed herein constitutes forward ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Delaware 86-0845127 (State or other jurisdiction of incorporation or organization) 6900 E Layton Avenue, 12th Floor, Denver, Colorado 80237 (Address of principal executive offices) (Zip Code) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 ...

"We are pleased to report first quarter 2024 results in-line with our previously announced guidance as revenue increased 3% year-over-year and adjusted EBITDA was $32 million," stated L. Heath Sampson, President and CEO. "We made significant progress in our strategic transformation to optimize the Company's best-scaled supportive care services platform. We completed another pivotal quarter in our NEMT segment, gaining conviction in our cost savings initiatives as the headwinds from Medicaid redetermination, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 86-0845127 (State or other jurisdiction of incor ...

ModivCare Inc. (NASDAQ:MODV) Q4 2023 Earnings Conference Call February 23, 2024 8:30 AM ET Company Participants Kevin Ellich - Head of Investor Relations Heath Sampson - President & Chief Executive Officer Barbara Gutierrez - Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Scott Fidel - Stephens Brooks O'Neil - Lake Street Capital Pito Chickering - Deutsche Bank Peter Lukas - CJS Securities Mike Petusky - Barrington Research Operator Good morning and welcome to ModivCare's F ...

Modivcare Reports Fourth Quarter and Full Year 2023 Financial Results; Issues 2024 Guidance Denver, CO – February 22, 2024 – Modivcare Inc. (the "Company" or "Modivcare") (Nasdaq: MODV), a technology- enabled healthcare services company that provides a suite of integrated supportive care solutions focused on improving patient outcomes, today reported financial results for the three months and full year ended December 31, 2023. Fourth Quarter 2023 Summary: Full Year 2023 Summary: Non-GAAP financial measure r ...

ModivCare Inc. (NASDAQ:MODV) Q3 2023 Earnings Conference Call November 3, 2023 8:30 AM ET Company Participants Kevin Ellich - Head of IR Heath Sampson - President and CEO Barbara Gutierrez - CFO Conference Call Participants Pito Chickering - Deutsche Bank Bob Labick - CJS Securities Scott Fidel - Stephens Brooks O'Neil - Lake Street Capital Mike Petusky - Barrington Research Operator Good morning, and welcome to ModivCare's Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please ...

Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Commission File Number 001-34221 ModivCare Inc. (Exact name of registrant as specified in its charter) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Delaware 86-0845127 (State or other jurisdiction ...

Financial Data and Key Metrics Changes - In Q2 2023, revenue increased by 11% year-over-year to $699 million, driven by 11% growth in mobility and the Home division [19] - Adjusted EBITDA for NEMT was approximately $29 million, down 38% year-over-year due to increased service expenses and a prior year benefit of $7 million from repricing [20] - Contract receivables collections increased to approximately $16 million in Q2 from $6 million in Q1, indicating improved cash flow [22] - The company lowered its adjusted EBITDA guidance due to higher NEMT utilization and associated costs [24] Business Line Data and Key Metrics Changes - NEMT revenue for Q2 was $497 million, with a 1.5% year-over-year increase in average monthly members to 34.3 million and a 9% increase in revenue per member per month [30] - The Home division's personal care revenue increased by 11% year-over-year to $180 million, driven by a 3.4% growth in hours and a 7% increase in revenue per hour [31] - RPM segment revenue increased by 15% year-over-year to $19 million, supported by strong referral sales [21] Market Data and Key Metrics Changes - The company anticipates Medicaid redetermination could create an adjusted EBITDA headwind of approximately $5 million to $10 million for the second half of 2023 [11] - The company expects regular growth in Medicaid and MA programs to counterbalance the impacts of redetermination [11] Company Strategy and Development Direction - The company's strategy focuses on digital transformation and operational excellence, with a strong emphasis on automation and improving member engagement through omnichannel options [14][15] - The company is pursuing approximately $700 million in new opportunities in its MCO pipeline, aiming to provide holistic solutions beyond transportation [16] - The company is committed to growing supportive care services focused on social determinants of health [29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in generating substantial cash flow in the second half of 2023, driven by normalized working capital and strong core cash flow [9][37] - The company is optimistic about its long-term growth strategy despite the challenges posed by Medicaid redetermination [35] - Management highlighted the importance of automation and cost-saving initiatives to improve margins and cash flow generation [91][119] Other Important Information - The company ended Q2 with approximately $7 million in cash and had $126.5 million drawn on its $325 million revolver [33] - The company continues to target a net leverage of three times, expecting to achieve this through debt reduction and EBITDA growth [34] Q&A Session Summary Question: What is the impact of Medicaid redetermination on the company? - Management expects a 10% to 15% reduction in the number of Medicaid lives covered, with an estimated EBITDA impact of $5 million to $10 million for 2023 [11][82] Question: How are margins looking in the full-risk versus shared-risk categories? - Full-risk contracts generally have higher margins but come with more variability, while shared-risk contracts offer more predictability with slightly lower margins [63][67] Question: What are the expected wage increases for caregivers? - Management indicated that wage increases are expected to be competitive in the marketplace, particularly in states with higher minimum wage requirements [72][94] Question: How does the company plan to manage cash flow and debt? - The company plans to pay down its revolver by $30 million to $50 million in the second half of the year, with expectations of generating cash flow in line with its guidance [128][130] Question: What is the company's strategy for automation and cost savings? - The company is implementing automation to reduce call center interactions and improve efficiency, expecting significant cost savings to materialize in 2024 [160][161]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 86-0845127 (State or other jurisdiction of i ...